A phase II trial with monoclonal antibody WX-G250 in advanced renal cell carcinoma

Author： Bleumer I.   Beck J.   Hofmann R.   Kruit W.   Warnaar S.   Mala C.   Ullrich S.   Huber C.   Debruyne F.M.J.   Oosterwijk E.   Mulders P.F.A.  

Publisher： Elsevier

ISSN： 1569-9056

Source： European Urology Supplements, Vol.1, Iss.1, 2002-01, pp. : 112-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tamoxifen and colchicine-modulated vinblastine followed by 5-fluorouracil in advanced renal cell carcinoma: a phase II study

By Liu J.-H.   Yang M.-H.   Fan F.S.   Yen C.-C.   Wang W.-S.   Chang Y.-H.   Chen K.-K.   Chen P.-M.  

Urology, Vol. 57, Iss. 4, 2001-04 ,pp. : 650-654

Elsevier

Access to resources Recommend Favorite

Targeting of recombinant adenoviruses to the human renal cell carcinoma associated G250/caix protein

By Jongmans W.   Oosterwijk E.   Van den Oudenalder K.   Bleumer I.   Tiemessen D.   Mulders P.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 181-181

Elsevier

Access to resources Recommend Favorite

Renal cell carcinoma-associated G250 methylation and expression: in vivo and in vitro studies

By Grabmaier K.   de Weijert M.   Uemura H.   Schalken J.   Oosterwijk E.  

Urology, Vol. 60, Iss. 2, 2002-08 ,pp. : 357-362

Elsevier

Access to resources Recommend Favorite

Increased intracellular doxorubicin by anti-Fas monoclonal antibody: a mechanism that enhances the cytotoxicity in renal cell carcinoma cells

By Wu X.-X.   Kakehi Y.   Mizutani Y.   Terachi T.   Ogawa O.  

Urology, Vol. 57, Iss. 5, 2001-05 ,pp. : 993-998

Elsevier

Access to resources Recommend Favorite

Antibody therapy in renal cell carcinoma

By Oosterwijk Egbert  

World Journal of Urology, Vol. 26, Iss. 2, 2008-04 ,pp. : 141-146

Springer Publishing Company

Access to resources Recommend Favorite